NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 5.252
EU - Europa 3.906
AS - Asia 1.693
SA - Sud America 149
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 4
Totale 11.032
Nazione #
US - Stati Uniti d'America 5.215
IT - Italia 1.427
GB - Regno Unito 1.089
CN - Cina 531
SG - Singapore 513
SE - Svezia 433
HK - Hong Kong 302
DE - Germania 266
TR - Turchia 212
UA - Ucraina 173
BR - Brasile 134
RU - Federazione Russa 118
FI - Finlandia 105
FR - Francia 71
BG - Bulgaria 63
NL - Olanda 38
KR - Corea 29
IN - India 28
CA - Canada 22
IR - Iran 21
BE - Belgio 17
IE - Irlanda 16
LT - Lituania 15
EU - Europa 12
SI - Slovenia 11
AT - Austria 10
CH - Svizzera 10
ID - Indonesia 10
VN - Vietnam 10
ES - Italia 9
PL - Polonia 9
MX - Messico 8
AR - Argentina 6
BD - Bangladesh 5
CO - Colombia 5
IQ - Iraq 5
MA - Marocco 5
GR - Grecia 4
MY - Malesia 4
AU - Australia 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
PA - Panama 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CU - Cuba 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
JO - Giordania 2
LV - Lettonia 2
MG - Madagascar 2
TH - Thailandia 2
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
JM - Giamaica 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SM - San Marino 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11.032
Città #
Southend 832
Santa Clara 790
Woodbridge 496
Fairfield 433
Chandler 429
Jacksonville 352
Ashburn 335
Singapore 332
Hong Kong 299
Ann Arbor 260
Houston 258
Nyköping 246
Dearborn 234
Wilmington 195
Seattle 169
Beijing 153
London 152
Cambridge 150
Rome 124
Izmir 120
Milan 116
Hefei 106
Princeton 70
Sofia 62
Eugene 61
San Diego 61
Modena 53
Naples 53
Shanghai 43
Helsinki 40
Frankfurt am Main 39
Des Moines 37
Moscow 36
Munich 36
New York 34
Bologna 30
Seoul 28
Florence 26
Palermo 25
Los Angeles 24
Bari 23
Philadelphia 20
Turin 19
Brussels 16
Dublin 16
Guangzhou 16
Redwood City 16
Catania 15
San Mateo 15
Augusta 14
Brescia 14
Columbus 14
Council Bluffs 14
Boardman 13
Nanjing 12
Norwalk 12
Parma 11
Falls Church 10
Mashhad 10
Ottawa 10
The Dalles 10
Verona 10
Bremen 9
Grafing 9
Perugia 9
Pescara 9
Ardabil 8
Cosenza 8
Jakarta 8
Kunming 8
Padova 8
Rio de Janeiro 8
São Paulo 8
Treviso 8
Bergamo 7
Pisa 7
Toronto 7
Turku 7
Carpi 6
Casalecchio di Reno 6
Ferrara 6
Genoa 6
Jinan 6
Novara 6
Phoenix 6
Piacenza 6
Rio Saliceto 6
Trieste 6
Indiana 5
Kraków 5
Legnano 5
Monmouth Junction 5
Nuremberg 5
Saint-martin-du-tertre 5
Angri 4
Auburn Hills 4
Bangalore 4
Belo Horizonte 4
Boston 4
Cascina 4
Totale 7.891
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.428
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 246
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 235
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 227
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 209
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 208
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 207
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 206
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 203
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 199
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 190
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 190
Age-related comorbidities in people living with HIV 184
Detectable HIV viral load is associated with metabolic syndrome 181
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 178
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 178
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 177
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 174
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 169
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 169
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 165
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 164
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 163
Severity of lipodystrophy is associated with decreased health-related quality of life 160
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 158
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 158
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 157
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 154
Virologic failure and metabolic syndrome in patients with HIV infection 154
How do frailty mediate pathway leading to disability 154
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 150
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 149
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 148
Virologic failure and metabolic syndrome in patients with HIV infection 147
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 146
Validity of body image perception in women with HIV. 145
Does lipodistrophy affect quality of life? 145
È possibile un counselling HIV su internet? 143
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 141
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 140
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 140
Relapse of HIV-related buffalo hump after liposuction 139
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 137
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 137
Body Image perception in HIV infected women with body fat redistribution. 136
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 134
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 131
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 130
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 129
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 129
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 127
Prevalence and risk factors of pubic lipomas in HIV-infected patients 123
Lipodystrophy and quality of life: a prospective study 122
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 119
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 117
HIV counselling looks for new target and methods web versus face to face counselling 116
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 115
Qual è il rapporto tra qualità di vita e lipodistrofia 112
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 111
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 106
HIV counselling and prevention on the WEB 105
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 103
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 97
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 71
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 68
Totale 11.153
Categoria #
all - tutte 39.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.215 100 43 103 118 182 71 109 131 82 118 95 63
2021/2022987 21 158 63 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20252.944 117 69 73 227 624 427 221 127 337 97 294 331
2025/202688 88 0 0 0 0 0 0 0 0 0 0 0
Totale 11.153